| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |